CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $737,000 | 0.0% | 39,862 | 0.0% | 0.02% | -46.4% |
| Q3 2018 | $737,000 | -19.3% | 39,862 | -0.2% | 0.03% | -24.3% |
| Q2 2018 | $913,000 | -24.5% | 39,924 | -6.1% | 0.04% | -27.5% |
| Q1 2018 | $1,209,000 | +34.5% | 42,502 | -0.2% | 0.05% | +37.8% |
| Q4 2017 | $899,000 | -35.1% | 42,600 | -44.1% | 0.04% | -32.7% |
| Q3 2017 | $1,386,000 | +16.9% | 76,275 | -0.3% | 0.06% | +12.2% |
| Q2 2017 | $1,186,000 | – | 76,498 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |